Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 [Phase 1]
Phase 1 clinical trial update evaluating tumor cellular proliferation using the PET radiotracer [18F]ISO-1 in patients with breast cancer, h…
-
CLINICAL_TRIALS research · 2014-12-09Clinical Trial Update: Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients
A completed clinical trial evaluating whether gene polymorphisms and gene products can serve as biomarkers of aging and predict chemotherapy…
-
CLINICAL_TRIALS withdrawal · 2014-12-09Clinical Trial Update: Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin [Phase 2]
Phase 2 clinical trial of electrochemotherapy for breast cancer with skin metastases has been withdrawn.
-
CLINICAL_TRIALS research · 2014-12-09Clinical Trial Update: Everolimus trIal for Advanced prememopausaL Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update for everolimus in advanced premenopausal metastatic breast cancer; status is not specified.
-
CLINICAL_TRIALS research · 2014-12-09Clinical Trial Update: An Interactive Empowerment Tool for Breast Cancer Patients [NA]
This entry describes a University of Milan clinical trial developing an interactive empowerment tool for patients with breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-12-08Clinical Trial Update: Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating paclitaxel with BKM120 before surgery in stage II/III estrogen receptor-positive, HER2-negative breast cancer has…
-
FDA approval · 2014-12-05FDA Approved: CAPECITABINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Capecitabine from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer [Phase 3]
A Phase 3 trial comparing intra-operative radiotherapy with post-operative radiotherapy for women with early breast cancer has completed, wi…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Proton Therapy for Lymph Nodes in Breast Cancer [NA]
This clinical trial update notes the completion of a study evaluating proton therapy to target lymph nodes in breast cancer and that results…
-
CLINICAL_TRIALS research · 2014-12-05Clinical Trial Update: GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians [NA]
This clinical trial evaluated an educational intervention aimed at improving how family physicians deliver genetics services for breast canc…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer [Phase 1]
Phase 1 trial results for MM-111 in combination with Herceptin in patients with advanced HER2-amplified, heregulin-positive breast cancer we…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors [Phase 2]
A Phase II trial evaluating trastuzumab plus paclitaxel for HER2-positive locally advanced breast cancer and epirubicin plus docetaxel for H…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen [Phase 2]
A Phase 2 study evaluated the combination of lapatinib and tamoxifen in patients with locally advanced or metastatic breast cancer that prog…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Menopause and Meditation for Breast Cancer Survivors [Phase 1, Phase 2]
A clinical trial update indicates completion of Phase 1 and Phase 2 studies evaluating menopause and meditation for breast cancer survivors.
-
CLINICAL_TRIALS research · 2014-12-03Clinical Trial Update: Behavioral Weight Loss and Exercise After Treatment (BEAT) [NA]
This Clinical Trial Update describes the BEAT study, which investigates behavioral weight loss and exercise after treatment in breast cancer…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women [Phase 2]
Phase 2 clinical trial assessing whether a telephone-based prevention care manager increases cancer screening rates among minority and low-i…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer [Phase 2]
A Phase 2 trial sponsored by Bayer evaluates the safety and efficacy of a new chemotherapy agent for metastatic breast cancer; the study sta…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts.
The study evaluating Somo•v in combination with digital mammography for breast cancer screening in women with dense breasts has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Polymorphism Interaction to Predict Bevacizumab Efficacy
A completed clinical trial examined polymorphism interactions to predict the efficacy of bevacizumab in metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity [Phase 3]
A Phase 3 clinical trial evaluating candesartan versus placebo to prevent trastuzumab-associated cardiotoxicity in breast cancer, with the s…
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: Exercise in Breast Cancer Survivors [NA]
A clinical trial evaluating exercise in breast cancer survivors sponsored by the University of Mississippi Medical Center has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility [Phase 2]
Phase II study evaluating dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER2-amplified breast cance…
-
CLINICAL_TRIALS trial_result · 2014-11-27Clinical Trial Update: Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluated ixabepilone with cyclophosphamide as neoadjuvant therapy for HER-2 negative breast cancer; results have b…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss [Phase 4]
Phase 4 clinical trial update on using zoledronic acid to prevent cancer therapy-induced bone loss in premenopausal women with hormone recep…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer [Phase 2]
This entry reports a Phase 2 clinical trial by the Chinese Academy of Medical Sciences focused on optimizing neoadjuvant regimens for breast…